Preparing for Hurricane Florence in Pharma

Nice Insight

FDA Analysis

FDA Analysis Shows Reduced Competition for First-in-Class Drugs

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Licensing

Oxford BioMedica Completes Licensing Agreement with Bioverativ Inc.

Emilie Branch

Pharma's Almanac

Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

Guy Tiene

Nice Insight

Acquistion

Celanese Completes Omni Acquisition

Nigel Walker

Nice Insight

Healthcare

Leading Companies Taking Action to Address Healthcare

Guy Tiene

Nice Insight

CAR-T

Pfizer Joins Gilead in CAR-T Development   

Cynthia A. Challener, Ph.D.

Pharma's Almanac

FDA

FDA and DoD Launch Joint Program to Accelerate Drug Development

Emilie Branch

Pharma's Almanac

Cell and Gene Therapy

Cell Therapy Companies Can Now Have Improved Cell Thawing Capabilities

Nigel Walker

Nice Insight

FDA Approval

FDA to Expand the Use of Gilotrif

Nigel Walker

Nice Insight

Expanded Capacity

Abbvie to Add Jobs in Ireland

Emilie Branch

Pharma's Almanac

Acquisition

Sanofi Buys Bioverativ

Guy Tiene

Nice Insight

Acquisition

Charles River Laboratories Continues to Grow Through Acquisition

Nigel Walker

Nice Insight

Innovation

Harvard Researchers Use Chip Technology to Investigate New Anti-inflammatory Drugs

Emilie Branch

Pharma's Almanac

Supplier

Abzena Selects Sartorius Stedum Biotech as Supplier of Single-Use Tech

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Merger

CMC Biologics Becomes AGC Biologics

Guy Tiene

Nice Insight

EU Approves AstraZeneca’s Respiratory Biologic

Nigel Walker

Nice Insight

Partnership

Boehringer Ingelheim and Adimab Partner on Antibodies

Emilie Branch

Pharma's Almanac

Bioprinting

Sebaceous Glands in 3D

Guy Tiene

Nice Insight

Digital Platform

Clinical Decision-support Software to be Developed by Roche and GE Healthcare

Nigel Walker

Nice Insight